Literature DB >> 3527093

Platelet damage by protamine and the protective effect of prostacyclin: an experimental study in dogs.

A J Velders, C R Wildevuur.   

Abstract

Protamine is given after cardiopulmonary bypass to reverse the effect of heparin. However, the adverse effects of an overdose have not been fully evaluated. In this canine study, a standard dose of one bolus of heparin (300 IU per kilogram of body weight) was neutralized by an infusion of protamine hydrochloride in a 1:2 ratio. Platelet number and function were severely reduced by this overdose of protamine, and this finding correlated with a prolongation of the bleeding time. Giving a titrated dose of protamine hydrochloride to reverse heparin activity, measured by the activated clotting time, affected neither platelet number nor function. When prostacyclin (0.5 microgram/kg/min) was infused during administration of an overdose of protamine, platelets again were not affected by the excess of protamine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3527093     DOI: 10.1016/s0003-4975(10)60512-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

Review 1.  Are We Able to Dose Protamine Accurately Yet? A Review of the Protamine Conundrum.

Authors:  Patrick Hecht; Martin Besser; Florian Falter
Journal:  J Extra Corpor Technol       Date:  2020-03

2.  Heparin antagonism by polyvalent display of cationic motifs on virus-like particles.

Authors:  Andrew K Udit; Chris Everett; Andrew J Gale; Jennifer Reiber Kyle; Mihri Ozkan; M G Finn
Journal:  Chembiochem       Date:  2009-02-13       Impact factor: 3.164

3.  The Inhibitory Effect of Protamine on Platelets is Attenuated by Heparin without Inducing Thrombocytopenia in Rodents.

Authors:  Joanna Miklosz; Bartlomiej Kalaska; Kamil Kaminski; Malgorzata Rusak; Krzysztof Szczubialka; Maria Nowakowska; Dariusz Pawlak; Andrzej Mogielnicki
Journal:  Mar Drugs       Date:  2019-09-17       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.